Study Summary
This trial looks at two ways of diagnosing prostate cancer to see which is more accurate.
- Unknown Health Status
- Elevated Prostate Specific Antigen (PSA)
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: Up to 5 years
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Arm I (SR-Bx)
1 of 2
Arm II (MRI, MRUS-Bx, SR-Bx)
1 of 2
Active Control
Experimental Treatment
400 Total Participants · 2 Treatment Groups
Primary Treatment: Biopsy of Prostate · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Male Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How many centers are implementing this trial currently?
"Multiple medical centres have begun recruiting for this clinical trial, including the University of Maryland in Baltimore, UT Southwestern/Simmons Cancer Center-Dallas in Dallas and USC / Norris Comprehensive Cancer Centre in Los Angeles. Additionally, four other research sites are also enrolling participants." - Anonymous Online Contributor
Is recruitment for this investigation actively taking place?
"According to clinicaltrials.gov, this medical investigation is actively seeking volunteers. The trial was initially posted on September 25th 2017 and most recently updated on August 5th 2022." - Anonymous Online Contributor
What is the current size of enrolment for this trial?
"Affirmative. The clinical trial is still looking for individuals to take part in the study and its details were last updated on August 5th 2022, as seen on clinicaltrials.gov. 400 persons must be recruited from 7 different medical sites before the research can begin." - Anonymous Online Contributor